Profile
Company Profile
Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch has received regulatory authorization to market AC5® Advanced Wound System and AC5® Topical Hemostat as medical devices in the United States and Europe, respectively. Arch's development stage product candidates include AC5-G™, AC5-V® and AC5® Surgical Hemostat, among others.1,2
1. AC5-G, AC5-V, and AC5 Surgical Hemostat are currently investigational devices limited by law to investigational use.
2. AC5, AC5-G, AC5-V and associated logos are trademarks and/or registered trademarks of Arch Therapeutics, Inc. and/or its subsidiaries.
Company Info
Address:
235 Walnut Street
Suite 6
Framingham, MA 01702 US
Telephone:
855-340-2784
Industry Classifications
Sector:
Industrials
Industry:
Conglomerates
NAICS:
Offices of Other Holding Companies (551112)
SIC:
Offices Of Holding Companies, Not Elsewhere Classified (6719)